Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Religare IPO and Saamya Biotech IPO.
Religare IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE, NSE while Saamya Biotech IPO is a Mainline Fixed Price Issue proposed to list at BSE.
| Religare IPO | Saamya Biotech IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Fixed Price Issue |
| Listing At | BSE, NSE | BSE |
| Lead Managers | Citigroup Global Markets India Private Limited Axis Capital Limited |
Uti Securities Ltd |
| Registrar | Kfin Technologies Limited | Aarthi Consultants Pvt Ltd. |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Religare IPO is up to ₹140.16 Cr whereas the issue size of the Saamya Biotech IPO is up to ₹15.00 Cr. The final issue price of Religare IPO is ₹185.00 per share and of Saamya Biotech IPO is ₹10.00 per share.
| Religare IPO | Saamya Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹160.00 per share | |
| Issue Price (Upper) | ₹185.00 per share | |
| Issue Price (Final) | ₹185.00 per share | ₹10.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 35 shares | 500 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 75,76,102 shares | 1,50,00,000 shares |
| Issue Size Total (Amount) | up to ₹140.16 Cr | up to ₹15.00 Cr |
Religare IPO opens on Oct 29, 2007, while Saamya Biotech IPO opens on Sep 25, 2007. The closing date of Religare IPO and Saamya Biotech IPO is Nov 01, 2007, and Sep 28, 2007, respectively.
| Religare IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 29, 2007 | Sep 25, 2007 |
| Issue Close | Nov 01, 2007 | Sep 28, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Religare IPO P/E ratio is , as compared to Saamya Biotech IPO P/E ratio of .
| Religare IPO | Saamya Biotech IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 60.41% | 100% |
| Promoter Shareholding (Post-Issue) | 54.36% | 35% |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 7.81%% |
In the Religare IPO retail investors (RII) are offered while in Saamya Biotech IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Religare IPO and in Saamya Biotech IPO.
| Religare IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Religare IPO subscribed 160.56x in total, whereas Saamya Biotech IPO subscribed .
| Religare IPO | Saamya Biotech IPO | |
|---|---|---|
| QIB (times) | 184.95x | |
| NII (times) | 215.45x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 93.50x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 160.56x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
